Pharyngocutaneous fistula: a common complication following laryngectomy: JAMA

Written By :  Dr. Nandita Mohan
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-08-24 03:30 GMT   |   Update On 2021-08-24 05:20 GMT

Pharyngocutaneous fistula (PCF) results in an inflammatory reaction, but its association with the rate of locoregional and distant control, disease-free survival, and overall survival in laryngeal cancer remains uncertain. A recent multicenter retrospective cohort study conducted by a team of researchers from the Princess Margaret Cancer Centre, University Health Network, Toronto,...

Login or Register to read the full article

Pharyngocutaneous fistula (PCF) results in an inflammatory reaction, but its association with the rate of locoregional and distant control, disease-free survival, and overall survival in laryngeal cancer remains uncertain.

A recent multicenter retrospective cohort study conducted by a team of researchers from the Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada found that development of pharyngocutaneous fistula after salvage laryngectomy is associated with an increased risk for the development of distant metastases.

The study is published in the JAMA Otolaryngology- Head & Neck Surgery.

The objective of the study was to determine if pharyngocutaneous fistula after salvage laryngectomy is associated with locoregional and distant control, disease-free survival, and/or overall survival.

A total of 550 patients who underwent salvage laryngectomy for recurrent laryngeal cancer were included in the study. The median follow-up time was 5.7 years (range, 0-18 years).

The results revealed that all the 550 patients (mean [SD] age, 64 [10.4] years; men, 465 [85%]) met inclusion criteria. Out of the entire sample, pharyngocutaneous fistula occurred in 127 patients (23%).

The difference in locoregional control between the group of patients with pharyngocutaneous fistula (75%) and the non– pharyngocutaneous fistula (72%) group was 3% (95% CI, −6% to 12%).

The difference in overall survival between the group with pharyngocutaneous fistula (44%) and the non– pharyngocutaneous fistula group (52%) was 8% (95% CI, −2% to 20%). The difference in disease-free survival between pharyngocutaneous fistula and non– pharyngocutaneous fistula groups was 6% (95% CI, −4% to 16%).

Furthermore, in the multivariable model, patients with pharyngocutaneous fistula were at a 2-fold higher rate of distant metastases (hazard ratio, 2.00; 95% CI, 1.22 to 3.27). Distant control was reduced in those with pharyngocutaneous fistula, a 13% (95% CI, 3% to 21%) difference in 5-year distant control.

As a result, the authors concluded that development of pharyngocutaneous fistula after salvage laryngectomy is associated with an increased risk for the development of distant metastases.

doi:10.1001/jamaoto.2021.1545



Tags:    
Article Source : JAMA Otolaryngology- Head & Neck Surgery

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News